Borowska H,Aieiszewska E,Czaudema P,Sawicki B .2004 .Daetinomycin-induced veno-oeclusive diseaseinrats.The hepatoproteetive action of amifostine. Evaluation in a light and eleetron microseope. Folia Morph-ologiea. , 63(1) : 91-93.
Boué J,Basso L,Cenac N,Blanpied C,Rolli-Derkinderen M,Neunlist M,Vergnolle N,Coppell JA,Richardson PG,Soiffer R,Martin PL,Kernan NA,Chen A,Guinan E,Vogelsang G,Krishnan A,Giralt S,Revta C,Carreau NA,Iacobelli M,Carreras E,Ruutu T,Barbui T,Antin JH,Niederwieser D .2010 .Hepatic VenoOcclusive Disease following Stem Cell Transplantation: Incidence, Clinical Course and Outcome. Biol. Blood Marrow Transplant, 16(2) : 157-168.
Carreras E .2000 .Veno-occlusive disease of the liver after hemopoietic cell transplantation. Eur. J. Haematol., 64(5) : 281-291.
Carson RT,Vignali DA .1999 .Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J. Immunol. Methods., 227(1-2) : 41-52.
Chen MY,Cai JT,Du Q,Wang LJ,Chen JM,Shao LM JM .2008 .Reliable experimental model of hepatic veno-occlusive disease caused by monocrotaline. Hepatobiliary Pancreat Dis. lnt., 7(4) : 395-400.
Chen Z,Huo JR,Yang L,Zhu HY .2011 .Effect of ligustrazine on mouse model of hepatic veno-occlusive disease induced by Gynura segetum. J. Gastroenterol Hepatol, 26(6) : 1016-1021.
Coppell JA,Brown SA,Perry DJ SA .2003 .Veno occlusive disease: Cytokines, genetics and haemostasis. Blood Rev, 17(2) : 63-70.
Corbacioglu S,Carreras E,Mohty M,Pagliuca A,Ballabio M,Hume R,Bandiera V,Finetto G,Richardson PG .2015 .Defibrotide for the treatment of hepatic veno-occlusive disease:an update from the international compassionate use program in 710 patients. Blood Marrow Transplant, 21(2) : S108-S108.
DeLeve LD .1996 .Cellular target of cyclophosphamide toxicity in the murine liver: Role of glutathione and site of metabolic activation. Hepatology, 24(4) : 830-837.
Deleve LD,Mccuskey RS,Wang XD,Hu L,McCuskey MK,Epstein RB,Kanel GC .1999 .Characterization of a reproducible rat model of hepatic veno occclusive disease. Hepatology, 29(6) : 1779-1793.
Diehl AM .2002 .Liver regeneration. , 7 : e301-e314.
Dietrich G .2014 .Endogenous regulation of visceral pain via production of opioids by colitogenic CD4(+) T cells in mice. Gastroenterology, 146(1) : 166-175.
Enric C,Marina DB,Laura RO,Carmen M,Francesc FA,Montserrat R .2011 .The incidence of venoocclusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol. Blood Marrow Transplant, 17(11) : 1713-1720.
Esmon CT .2004 .Crosstalk between inflammation and thrombosis. Maturitas, 47(4) : 305-314.
Fan CQ,Crawford JM .2014 .Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J. Clin. Exp, 4(4) : 332-346.
Faouzi S,Lepreux S,Bedin C,Dubuisson L,Balabaud C,Bioulac-Sage P,Desmoulière A,Rosenbaum J .1999 .Activation of cultured rat hepatic stellate cells by tumoral hepatocytes. Lab Invest, 79(4) : 485-493.
Gorski JC,Wang Z,Haehner-Daniels BD,Wrighton SA,Hall SD .2000 .The effect of hormone replacement therapy of CYP3A activity. Clin. Phannacol, 68(4) : 412-417.
Gozdzik J,Krasowska-Kwiecień A,Wedrychowicz A .2008 .Sinusoidal obstruction disease (SOS), previous hepatic venoocclusive disease (VOD)--still serious complication after hematopoietic stem cell transplantation. Przegl Lek, 65(4) : 203.
Kalayoglu-Besisik S,Yenerel MN,Caliskan Y,Ozturk S,Besisik F,Sargin D F .2005 .Time related changes in the incidence, severity and clinical outcome of hepatic veno occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years. Transplant Proc., 37(5) : 2285-2289.
Knolle PA .2003 .Limmer A. Control of immune responses by savenger liver endothelial cells. Swiss Med Wkly, 133 : 501-506.
Lee SH,Yoo KH,Sung KW,Koo HH,Kwon YJ,Kwon MM,Park HJ,B-K P,Kim YY,Park JA .2010 .Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: Incidence, risk factors, and outcome. Bone Marrow Transplant, 45(8) : 1287-1293.
Marra F .2002 .Chemokines in liver inflammation and fibrosis. , 7 : d1899-d1914.
Pihusch V,Pihusch M,Penovici M,Kolb HJ,Hiller E,Pihusch R .2005 .Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation. Thromb. Res, 116(3) : 233-240.
Mohty M,Malard F,Abecassis M,Aerts E,Alaskar A,Aljurf M,Arat M,Bader P,Baron F,Bazarbachi A .2015 .Sinusoidal obstruction syndrome/venoocclusive disease: Current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant, 50(6) : 781-789.
Richardson P,Guinan E .2001 .Hepatic veno-occlusive disease following hematopoietic stem cell transplantation. Acta. Haematol, 106(1-2) : 57-68.
Richardson PG,Triplett BM,Ho VT,Chao N,Dignan FL,Maglio M,Mohty M .2018 .Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Expert. Rev. Clin. Pharmacol, 11(2) : 113-124.
Schildberg FA,Hegenbarth SI,Schumak B,Scholz K,Limmer A,Knolle PA .2008 .Liver sinusoidal endothelial cells veto CD8 T cell activation by antigenpresenting dendritic cells. Eur. J. Immunol., 38(4) : 957-967.
Tack DK,Letendre L,Kamath PS,Tefferi A .2001 .Development of hepatic veno-occlusive disease after Mylotarg infusion for relapsed acute myeloid leukemia. Bone Marrow Transplantation, 28(9) : 895-897.
Tefferi A,Kumar S,Wolf RC,Lacy MQ,Inwards DJ,Gloor J M RC,Kamath PS,Litzow MR .2001 .Charcoal hemofiltration for hepatic venoocclusive disease after hematopoietic stem cell transplantation. Bone Marrow Transplantation, 28 : 997-999.
Valla DC,Cazals-Hatem D .2016 .Sinusoidal obstruction syndrome. Clin. Res. Hepatol. Gastroenterol., 40(4) : 378-385.
Yang M,Ruan J,Fu PP,Lin G PP .2016 .Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloidinduced hepatotoxicity. Chem. Biol. Interact, 243 : 119-126.
Zeng L,An L,Fang T,Pan B,Sun H,Chen C,Cao J,Li Z,Xu K Z .2013 .A murine model of hepatic venoocclusive disease induced by allogeneic hematopoietic stem cell transplantation. Cell. Biochem. Biophys., 67(3) : 939-948.